nodes	percent_of_prediction	percent_of_DWPC	metapath
Pindolol—Shock—Irinotecan—pancreatic cancer	0.00152	0.00237	CcSEcCtD
Pindolol—Nervous system disorder—Irinotecan—pancreatic cancer	0.00151	0.00236	CcSEcCtD
Pindolol—Oedema—Gemcitabine—pancreatic cancer	0.0015	0.00235	CcSEcCtD
Pindolol—Cardiac failure—Epirubicin—pancreatic cancer	0.0015	0.00234	CcSEcCtD
Pindolol—Diarrhoea—Tamoxifen—pancreatic cancer	0.0015	0.00234	CcSEcCtD
Pindolol—Lethargy—Epirubicin—pancreatic cancer	0.00149	0.00233	CcSEcCtD
Pindolol—Cardiac failure congestive—Doxorubicin—pancreatic cancer	0.00149	0.00233	CcSEcCtD
Pindolol—Hyperhidrosis—Irinotecan—pancreatic cancer	0.00149	0.00233	CcSEcCtD
Pindolol—Confusional state—Fluorouracil—pancreatic cancer	0.00149	0.00233	CcSEcCtD
Pindolol—Abdominal pain—Sunitinib—pancreatic cancer	0.00148	0.00231	CcSEcCtD
Pindolol—Diarrhoea—Erlotinib—pancreatic cancer	0.00148	0.00231	CcSEcCtD
Pindolol—Oedema—Fluorouracil—pancreatic cancer	0.00148	0.00231	CcSEcCtD
Pindolol—Nervous system disorder—Gemcitabine—pancreatic cancer	0.00147	0.0023	CcSEcCtD
Pindolol—Hyperhidrosis—Gemcitabine—pancreatic cancer	0.00145	0.00227	CcSEcCtD
Pindolol—Nervous system disorder—Fluorouracil—pancreatic cancer	0.00145	0.00226	CcSEcCtD
Pindolol—Hot flush—Doxorubicin—pancreatic cancer	0.00145	0.00226	CcSEcCtD
Pindolol—Visual impairment—Docetaxel—pancreatic cancer	0.00145	0.00226	CcSEcCtD
Pindolol—Dizziness—Tamoxifen—pancreatic cancer	0.00145	0.00226	CcSEcCtD
Pindolol—Tachycardia—Fluorouracil—pancreatic cancer	0.00144	0.00225	CcSEcCtD
Pindolol—Hypotension—Irinotecan—pancreatic cancer	0.00144	0.00225	CcSEcCtD
Pindolol—Menopausal symptoms—Doxorubicin—pancreatic cancer	0.00143	0.00224	CcSEcCtD
Pindolol—Dizziness—Erlotinib—pancreatic cancer	0.00143	0.00223	CcSEcCtD
Pindolol—Hypotension—Gemcitabine—pancreatic cancer	0.0014	0.00219	CcSEcCtD
Pindolol—Insomnia—Irinotecan—pancreatic cancer	0.00139	0.00218	CcSEcCtD
Pindolol—Cardiac disorder—Docetaxel—pancreatic cancer	0.00139	0.00217	CcSEcCtD
Pindolol—Vomiting—Tamoxifen—pancreatic cancer	0.00139	0.00217	CcSEcCtD
Pindolol—Cardiac failure—Doxorubicin—pancreatic cancer	0.00139	0.00217	CcSEcCtD
Pindolol—Paraesthesia—Irinotecan—pancreatic cancer	0.00138	0.00216	CcSEcCtD
Pindolol—Lethargy—Doxorubicin—pancreatic cancer	0.00138	0.00216	CcSEcCtD
Pindolol—Hypotension—Fluorouracil—pancreatic cancer	0.00138	0.00216	CcSEcCtD
Pindolol—Rash—Tamoxifen—pancreatic cancer	0.00138	0.00215	CcSEcCtD
Pindolol—Dermatitis—Tamoxifen—pancreatic cancer	0.00138	0.00215	CcSEcCtD
Pindolol—Vomiting—Erlotinib—pancreatic cancer	0.00137	0.00215	CcSEcCtD
Pindolol—Dyspnoea—Irinotecan—pancreatic cancer	0.00137	0.00215	CcSEcCtD
Pindolol—Somnolence—Irinotecan—pancreatic cancer	0.00137	0.00214	CcSEcCtD
Pindolol—Headache—Tamoxifen—pancreatic cancer	0.00137	0.00214	CcSEcCtD
Pindolol—Musculoskeletal discomfort—Gemcitabine—pancreatic cancer	0.00137	0.00214	CcSEcCtD
Pindolol—Rash—Erlotinib—pancreatic cancer	0.00136	0.00213	CcSEcCtD
Pindolol—Dermatitis—Erlotinib—pancreatic cancer	0.00136	0.00213	CcSEcCtD
Pindolol—Angiopathy—Docetaxel—pancreatic cancer	0.00136	0.00213	CcSEcCtD
Pindolol—Insomnia—Gemcitabine—pancreatic cancer	0.00136	0.00212	CcSEcCtD
Pindolol—Dyspepsia—Irinotecan—pancreatic cancer	0.00136	0.00212	CcSEcCtD
Pindolol—Headache—Erlotinib—pancreatic cancer	0.00135	0.00212	CcSEcCtD
Pindolol—Mediastinal disorder—Docetaxel—pancreatic cancer	0.00135	0.00211	CcSEcCtD
Pindolol—Paraesthesia—Gemcitabine—pancreatic cancer	0.00135	0.00211	CcSEcCtD
Pindolol—Musculoskeletal discomfort—Fluorouracil—pancreatic cancer	0.00135	0.0021	CcSEcCtD
Pindolol—Asthenia—Sunitinib—pancreatic cancer	0.00134	0.0021	CcSEcCtD
Pindolol—Dyspnoea—Gemcitabine—pancreatic cancer	0.00134	0.00209	CcSEcCtD
Pindolol—Orthostatic hypotension—Epirubicin—pancreatic cancer	0.00134	0.00209	CcSEcCtD
Pindolol—Insomnia—Fluorouracil—pancreatic cancer	0.00134	0.00209	CcSEcCtD
Pindolol—Somnolence—Gemcitabine—pancreatic cancer	0.00134	0.00209	CcSEcCtD
Pindolol—Gastrointestinal disorder—Irinotecan—pancreatic cancer	0.00133	0.00208	CcSEcCtD
Pindolol—Fatigue—Irinotecan—pancreatic cancer	0.00133	0.00208	CcSEcCtD
Pindolol—Paraesthesia—Fluorouracil—pancreatic cancer	0.00133	0.00207	CcSEcCtD
Pindolol—Pruritus—Sunitinib—pancreatic cancer	0.00132	0.00207	CcSEcCtD
Pindolol—Pain—Irinotecan—pancreatic cancer	0.00132	0.00206	CcSEcCtD
Pindolol—Constipation—Irinotecan—pancreatic cancer	0.00132	0.00206	CcSEcCtD
Pindolol—Dyspnoea—Fluorouracil—pancreatic cancer	0.00132	0.00206	CcSEcCtD
Pindolol—Mental disorder—Docetaxel—pancreatic cancer	0.00131	0.00205	CcSEcCtD
Pindolol—Somnolence—Fluorouracil—pancreatic cancer	0.00131	0.00205	CcSEcCtD
Pindolol—Dyspepsia—Fluorouracil—pancreatic cancer	0.0013	0.00203	CcSEcCtD
Pindolol—Nausea—Tamoxifen—pancreatic cancer	0.0013	0.00203	CcSEcCtD
Pindolol—Gastrointestinal disorder—Gemcitabine—pancreatic cancer	0.0013	0.00203	CcSEcCtD
Pindolol—Fatigue—Gemcitabine—pancreatic cancer	0.00129	0.00202	CcSEcCtD
Pindolol—Constipation—Gemcitabine—pancreatic cancer	0.00128	0.00201	CcSEcCtD
Pindolol—Pain—Gemcitabine—pancreatic cancer	0.00128	0.00201	CcSEcCtD
Pindolol—Nausea—Erlotinib—pancreatic cancer	0.00128	0.00201	CcSEcCtD
Pindolol—Diarrhoea—Sunitinib—pancreatic cancer	0.00128	0.002	CcSEcCtD
Pindolol—Gastrointestinal disorder—Fluorouracil—pancreatic cancer	0.00127	0.00199	CcSEcCtD
Pindolol—Feeling abnormal—Irinotecan—pancreatic cancer	0.00127	0.00198	CcSEcCtD
Pindolol—Pain—Fluorouracil—pancreatic cancer	0.00126	0.00197	CcSEcCtD
Pindolol—Gastrointestinal pain—Irinotecan—pancreatic cancer	0.00126	0.00197	CcSEcCtD
Pindolol—Muscle spasms—Docetaxel—pancreatic cancer	0.00126	0.00196	CcSEcCtD
Pindolol—Dizziness—Sunitinib—pancreatic cancer	0.00124	0.00193	CcSEcCtD
Pindolol—Feeling abnormal—Gemcitabine—pancreatic cancer	0.00124	0.00193	CcSEcCtD
Pindolol—Orthostatic hypotension—Doxorubicin—pancreatic cancer	0.00124	0.00193	CcSEcCtD
Pindolol—Abdominal pain—Irinotecan—pancreatic cancer	0.00122	0.0019	CcSEcCtD
Pindolol—Feeling abnormal—Fluorouracil—pancreatic cancer	0.00122	0.0019	CcSEcCtD
Pindolol—Vomiting—Sunitinib—pancreatic cancer	0.00119	0.00186	CcSEcCtD
Pindolol—Rash—Sunitinib—pancreatic cancer	0.00118	0.00184	CcSEcCtD
Pindolol—Dermatitis—Sunitinib—pancreatic cancer	0.00118	0.00184	CcSEcCtD
Pindolol—Headache—Sunitinib—pancreatic cancer	0.00117	0.00183	CcSEcCtD
Pindolol—Syncope—Docetaxel—pancreatic cancer	0.00117	0.00183	CcSEcCtD
Pindolol—Pollakiuria—Epirubicin—pancreatic cancer	0.00117	0.00182	CcSEcCtD
Pindolol—Palpitations—Docetaxel—pancreatic cancer	0.00115	0.0018	CcSEcCtD
Pindolol—Weight increased—Epirubicin—pancreatic cancer	0.00115	0.0018	CcSEcCtD
Pindolol—Loss of consciousness—Docetaxel—pancreatic cancer	0.00115	0.00179	CcSEcCtD
Pindolol—Drowsiness—Epirubicin—pancreatic cancer	0.00113	0.00176	CcSEcCtD
Pindolol—Arthralgia—Docetaxel—pancreatic cancer	0.00111	0.00174	CcSEcCtD
Pindolol—Myalgia—Docetaxel—pancreatic cancer	0.00111	0.00174	CcSEcCtD
Pindolol—Chest pain—Docetaxel—pancreatic cancer	0.00111	0.00174	CcSEcCtD
Pindolol—Nausea—Sunitinib—pancreatic cancer	0.00111	0.00174	CcSEcCtD
Pindolol—Asthenia—Irinotecan—pancreatic cancer	0.00111	0.00173	CcSEcCtD
Pindolol—Conjunctivitis—Epirubicin—pancreatic cancer	0.0011	0.00171	CcSEcCtD
Pindolol—Dry mouth—Docetaxel—pancreatic cancer	0.00109	0.0017	CcSEcCtD
Pindolol—Sweating—Epirubicin—pancreatic cancer	0.00108	0.00169	CcSEcCtD
Pindolol—Pollakiuria—Doxorubicin—pancreatic cancer	0.00108	0.00169	CcSEcCtD
Pindolol—Asthenia—Gemcitabine—pancreatic cancer	0.00108	0.00168	CcSEcCtD
Pindolol—Confusional state—Docetaxel—pancreatic cancer	0.00107	0.00168	CcSEcCtD
Pindolol—Oedema—Docetaxel—pancreatic cancer	0.00107	0.00166	CcSEcCtD
Pindolol—Weight increased—Doxorubicin—pancreatic cancer	0.00106	0.00166	CcSEcCtD
Pindolol—Pruritus—Gemcitabine—pancreatic cancer	0.00106	0.00166	CcSEcCtD
Pindolol—Diarrhoea—Irinotecan—pancreatic cancer	0.00105	0.00165	CcSEcCtD
Pindolol—Shock—Docetaxel—pancreatic cancer	0.00105	0.00164	CcSEcCtD
Pindolol—Nervous system disorder—Docetaxel—pancreatic cancer	0.00105	0.00163	CcSEcCtD
Pindolol—Pruritus—Fluorouracil—pancreatic cancer	0.00104	0.00163	CcSEcCtD
Pindolol—Drowsiness—Doxorubicin—pancreatic cancer	0.00104	0.00163	CcSEcCtD
Pindolol—Tachycardia—Docetaxel—pancreatic cancer	0.00104	0.00162	CcSEcCtD
Pindolol—Bradycardia—Epirubicin—pancreatic cancer	0.00103	0.00161	CcSEcCtD
Pindolol—Diarrhoea—Gemcitabine—pancreatic cancer	0.00103	0.00161	CcSEcCtD
Pindolol—Dizziness—Irinotecan—pancreatic cancer	0.00102	0.00159	CcSEcCtD
Pindolol—Conjunctivitis—Doxorubicin—pancreatic cancer	0.00101	0.00158	CcSEcCtD
Pindolol—Diarrhoea—Fluorouracil—pancreatic cancer	0.00101	0.00158	CcSEcCtD
Pindolol—Sweating—Doxorubicin—pancreatic cancer	0.001	0.00156	CcSEcCtD
Pindolol—Hypotension—Docetaxel—pancreatic cancer	0.000996	0.00156	CcSEcCtD
Pindolol—Vomiting—Irinotecan—pancreatic cancer	0.00098	0.00153	CcSEcCtD
Pindolol—Dizziness—Fluorouracil—pancreatic cancer	0.000977	0.00153	CcSEcCtD
Pindolol—Visual impairment—Epirubicin—pancreatic cancer	0.000975	0.00152	CcSEcCtD
Pindolol—Rash—Irinotecan—pancreatic cancer	0.000972	0.00152	CcSEcCtD
Pindolol—Dermatitis—Irinotecan—pancreatic cancer	0.000971	0.00152	CcSEcCtD
Pindolol—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	0.000971	0.00152	CcSEcCtD
Pindolol—Headache—Irinotecan—pancreatic cancer	0.000966	0.00151	CcSEcCtD
Pindolol—Insomnia—Docetaxel—pancreatic cancer	0.000964	0.00151	CcSEcCtD
Pindolol—Paraesthesia—Docetaxel—pancreatic cancer	0.000957	0.00149	CcSEcCtD
Pindolol—Vomiting—Gemcitabine—pancreatic cancer	0.000955	0.00149	CcSEcCtD
Pindolol—Bradycardia—Doxorubicin—pancreatic cancer	0.000953	0.00149	CcSEcCtD
Pindolol—Dyspnoea—Docetaxel—pancreatic cancer	0.00095	0.00148	CcSEcCtD
Pindolol—Somnolence—Docetaxel—pancreatic cancer	0.000948	0.00148	CcSEcCtD
Pindolol—Rash—Gemcitabine—pancreatic cancer	0.000947	0.00148	CcSEcCtD
Pindolol—Dermatitis—Gemcitabine—pancreatic cancer	0.000946	0.00148	CcSEcCtD
Pindolol—Tinnitus—Epirubicin—pancreatic cancer	0.000944	0.00147	CcSEcCtD
Pindolol—Headache—Gemcitabine—pancreatic cancer	0.000941	0.00147	CcSEcCtD
Pindolol—Cardiac disorder—Epirubicin—pancreatic cancer	0.000939	0.00147	CcSEcCtD
Pindolol—Vomiting—Fluorouracil—pancreatic cancer	0.000939	0.00147	CcSEcCtD
Pindolol—Dyspepsia—Docetaxel—pancreatic cancer	0.000938	0.00147	CcSEcCtD
Pindolol—Rash—Fluorouracil—pancreatic cancer	0.000931	0.00145	CcSEcCtD
Pindolol—Dermatitis—Fluorouracil—pancreatic cancer	0.00093	0.00145	CcSEcCtD
Pindolol—Headache—Fluorouracil—pancreatic cancer	0.000925	0.00144	CcSEcCtD
Pindolol—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.00092	0.00144	CcSEcCtD
Pindolol—Fatigue—Docetaxel—pancreatic cancer	0.000919	0.00144	CcSEcCtD
Pindolol—Angiopathy—Epirubicin—pancreatic cancer	0.000918	0.00143	CcSEcCtD
Pindolol—Nausea—Irinotecan—pancreatic cancer	0.000916	0.00143	CcSEcCtD
Pindolol—Mediastinal disorder—Epirubicin—pancreatic cancer	0.000912	0.00142	CcSEcCtD
Pindolol—Pain—Docetaxel—pancreatic cancer	0.000911	0.00142	CcSEcCtD
Pindolol—Constipation—Docetaxel—pancreatic cancer	0.000911	0.00142	CcSEcCtD
Pindolol—Visual impairment—Doxorubicin—pancreatic cancer	0.000902	0.00141	CcSEcCtD
Pindolol—Nausea—Gemcitabine—pancreatic cancer	0.000892	0.00139	CcSEcCtD
Pindolol—Mental disorder—Epirubicin—pancreatic cancer	0.000887	0.00138	CcSEcCtD
Pindolol—Feeling abnormal—Docetaxel—pancreatic cancer	0.000878	0.00137	CcSEcCtD
Pindolol—Nausea—Fluorouracil—pancreatic cancer	0.000877	0.00137	CcSEcCtD
Pindolol—Tinnitus—Doxorubicin—pancreatic cancer	0.000873	0.00136	CcSEcCtD
Pindolol—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.000872	0.00136	CcSEcCtD
Pindolol—Cardiac disorder—Doxorubicin—pancreatic cancer	0.000869	0.00136	CcSEcCtD
Pindolol—Flatulence—Epirubicin—pancreatic cancer	0.000868	0.00136	CcSEcCtD
Pindolol—Tension—Epirubicin—pancreatic cancer	0.000864	0.00135	CcSEcCtD
Pindolol—Nervousness—Epirubicin—pancreatic cancer	0.000856	0.00134	CcSEcCtD
Pindolol—Angiopathy—Doxorubicin—pancreatic cancer	0.00085	0.00133	CcSEcCtD
Pindolol—Muscle spasms—Epirubicin—pancreatic cancer	0.000847	0.00132	CcSEcCtD
Pindolol—Mediastinal disorder—Doxorubicin—pancreatic cancer	0.000844	0.00132	CcSEcCtD
Pindolol—Abdominal pain—Docetaxel—pancreatic cancer	0.000843	0.00132	CcSEcCtD
Pindolol—Mental disorder—Doxorubicin—pancreatic cancer	0.00082	0.00128	CcSEcCtD
Pindolol—Flatulence—Doxorubicin—pancreatic cancer	0.000803	0.00125	CcSEcCtD
Pindolol—Tension—Doxorubicin—pancreatic cancer	0.0008	0.00125	CcSEcCtD
Pindolol—Nervousness—Doxorubicin—pancreatic cancer	0.000792	0.00124	CcSEcCtD
Pindolol—Vertigo—Epirubicin—pancreatic cancer	0.000791	0.00124	CcSEcCtD
Pindolol—Syncope—Epirubicin—pancreatic cancer	0.00079	0.00123	CcSEcCtD
Pindolol—Muscle spasms—Doxorubicin—pancreatic cancer	0.000784	0.00122	CcSEcCtD
Pindolol—Palpitations—Epirubicin—pancreatic cancer	0.000778	0.00122	CcSEcCtD
Pindolol—Loss of consciousness—Epirubicin—pancreatic cancer	0.000774	0.00121	CcSEcCtD
Pindolol—Asthenia—Docetaxel—pancreatic cancer	0.000765	0.00119	CcSEcCtD
Pindolol—Pruritus—Docetaxel—pancreatic cancer	0.000754	0.00118	CcSEcCtD
Pindolol—Arthralgia—Epirubicin—pancreatic cancer	0.00075	0.00117	CcSEcCtD
Pindolol—Chest pain—Epirubicin—pancreatic cancer	0.00075	0.00117	CcSEcCtD
Pindolol—Myalgia—Epirubicin—pancreatic cancer	0.00075	0.00117	CcSEcCtD
Pindolol—Anxiety—Epirubicin—pancreatic cancer	0.000747	0.00117	CcSEcCtD
Pindolol—Dry mouth—Epirubicin—pancreatic cancer	0.000733	0.00115	CcSEcCtD
Pindolol—Vertigo—Doxorubicin—pancreatic cancer	0.000732	0.00114	CcSEcCtD
Pindolol—Syncope—Doxorubicin—pancreatic cancer	0.000731	0.00114	CcSEcCtD
Pindolol—Diarrhoea—Docetaxel—pancreatic cancer	0.000729	0.00114	CcSEcCtD
Pindolol—Confusional state—Epirubicin—pancreatic cancer	0.000725	0.00113	CcSEcCtD
Pindolol—Palpitations—Doxorubicin—pancreatic cancer	0.00072	0.00112	CcSEcCtD
Pindolol—Oedema—Epirubicin—pancreatic cancer	0.000719	0.00112	CcSEcCtD
Pindolol—Loss of consciousness—Doxorubicin—pancreatic cancer	0.000716	0.00112	CcSEcCtD
Pindolol—Shock—Epirubicin—pancreatic cancer	0.000707	0.0011	CcSEcCtD
Pindolol—Nervous system disorder—Epirubicin—pancreatic cancer	0.000705	0.0011	CcSEcCtD
Pindolol—Dizziness—Docetaxel—pancreatic cancer	0.000705	0.0011	CcSEcCtD
Pindolol—Tachycardia—Epirubicin—pancreatic cancer	0.000702	0.0011	CcSEcCtD
Pindolol—Hyperhidrosis—Epirubicin—pancreatic cancer	0.000695	0.00109	CcSEcCtD
Pindolol—Arthralgia—Doxorubicin—pancreatic cancer	0.000694	0.00108	CcSEcCtD
Pindolol—Chest pain—Doxorubicin—pancreatic cancer	0.000694	0.00108	CcSEcCtD
Pindolol—Myalgia—Doxorubicin—pancreatic cancer	0.000694	0.00108	CcSEcCtD
Pindolol—Anxiety—Doxorubicin—pancreatic cancer	0.000692	0.00108	CcSEcCtD
Pindolol—Dry mouth—Doxorubicin—pancreatic cancer	0.000679	0.00106	CcSEcCtD
Pindolol—Vomiting—Docetaxel—pancreatic cancer	0.000678	0.00106	CcSEcCtD
Pindolol—Rash—Docetaxel—pancreatic cancer	0.000672	0.00105	CcSEcCtD
Pindolol—Hypotension—Epirubicin—pancreatic cancer	0.000672	0.00105	CcSEcCtD
Pindolol—Dermatitis—Docetaxel—pancreatic cancer	0.000671	0.00105	CcSEcCtD
Pindolol—Confusional state—Doxorubicin—pancreatic cancer	0.000671	0.00105	CcSEcCtD
Pindolol—Headache—Docetaxel—pancreatic cancer	0.000668	0.00104	CcSEcCtD
Pindolol—Oedema—Doxorubicin—pancreatic cancer	0.000665	0.00104	CcSEcCtD
Pindolol—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	0.000655	0.00102	CcSEcCtD
Pindolol—Shock—Doxorubicin—pancreatic cancer	0.000654	0.00102	CcSEcCtD
Pindolol—Nervous system disorder—Doxorubicin—pancreatic cancer	0.000652	0.00102	CcSEcCtD
Pindolol—Insomnia—Epirubicin—pancreatic cancer	0.00065	0.00102	CcSEcCtD
Pindolol—Tachycardia—Doxorubicin—pancreatic cancer	0.000649	0.00101	CcSEcCtD
Pindolol—Paraesthesia—Epirubicin—pancreatic cancer	0.000646	0.00101	CcSEcCtD
Pindolol—Hyperhidrosis—Doxorubicin—pancreatic cancer	0.000643	0.001	CcSEcCtD
Pindolol—Dyspnoea—Epirubicin—pancreatic cancer	0.000641	0.001	CcSEcCtD
Pindolol—Somnolence—Epirubicin—pancreatic cancer	0.000639	0.000998	CcSEcCtD
Pindolol—Nausea—Docetaxel—pancreatic cancer	0.000633	0.000989	CcSEcCtD
Pindolol—Dyspepsia—Epirubicin—pancreatic cancer	0.000633	0.000988	CcSEcCtD
Pindolol—Hypotension—Doxorubicin—pancreatic cancer	0.000622	0.000971	CcSEcCtD
Pindolol—Gastrointestinal disorder—Epirubicin—pancreatic cancer	0.000621	0.000969	CcSEcCtD
Pindolol—Fatigue—Epirubicin—pancreatic cancer	0.00062	0.000968	CcSEcCtD
Pindolol—Constipation—Epirubicin—pancreatic cancer	0.000615	0.00096	CcSEcCtD
Pindolol—Pain—Epirubicin—pancreatic cancer	0.000615	0.00096	CcSEcCtD
Pindolol—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	0.000606	0.000947	CcSEcCtD
Pindolol—Insomnia—Doxorubicin—pancreatic cancer	0.000602	0.00094	CcSEcCtD
Pindolol—Paraesthesia—Doxorubicin—pancreatic cancer	0.000597	0.000933	CcSEcCtD
Pindolol—Dyspnoea—Doxorubicin—pancreatic cancer	0.000593	0.000926	CcSEcCtD
Pindolol—Feeling abnormal—Epirubicin—pancreatic cancer	0.000592	0.000925	CcSEcCtD
Pindolol—Somnolence—Doxorubicin—pancreatic cancer	0.000591	0.000924	CcSEcCtD
Pindolol—Gastrointestinal pain—Epirubicin—pancreatic cancer	0.000588	0.000918	CcSEcCtD
Pindolol—Dyspepsia—Doxorubicin—pancreatic cancer	0.000586	0.000915	CcSEcCtD
Pindolol—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	0.000574	0.000897	CcSEcCtD
Pindolol—Fatigue—Doxorubicin—pancreatic cancer	0.000574	0.000896	CcSEcCtD
Pindolol—Pain—Doxorubicin—pancreatic cancer	0.000569	0.000888	CcSEcCtD
Pindolol—Constipation—Doxorubicin—pancreatic cancer	0.000569	0.000888	CcSEcCtD
Pindolol—Abdominal pain—Epirubicin—pancreatic cancer	0.000568	0.000888	CcSEcCtD
Pindolol—Feeling abnormal—Doxorubicin—pancreatic cancer	0.000548	0.000856	CcSEcCtD
Pindolol—Gastrointestinal pain—Doxorubicin—pancreatic cancer	0.000544	0.00085	CcSEcCtD
Pindolol—Abdominal pain—Doxorubicin—pancreatic cancer	0.000526	0.000821	CcSEcCtD
Pindolol—Asthenia—Epirubicin—pancreatic cancer	0.000516	0.000806	CcSEcCtD
Pindolol—Pruritus—Epirubicin—pancreatic cancer	0.000509	0.000794	CcSEcCtD
Pindolol—Diarrhoea—Epirubicin—pancreatic cancer	0.000492	0.000768	CcSEcCtD
Pindolol—Asthenia—Doxorubicin—pancreatic cancer	0.000477	0.000745	CcSEcCtD
Pindolol—Dizziness—Epirubicin—pancreatic cancer	0.000475	0.000743	CcSEcCtD
Pindolol—Pruritus—Doxorubicin—pancreatic cancer	0.000471	0.000735	CcSEcCtD
Pindolol—Vomiting—Epirubicin—pancreatic cancer	0.000457	0.000714	CcSEcCtD
Pindolol—Diarrhoea—Doxorubicin—pancreatic cancer	0.000455	0.000711	CcSEcCtD
Pindolol—Rash—Epirubicin—pancreatic cancer	0.000453	0.000708	CcSEcCtD
Pindolol—Dermatitis—Epirubicin—pancreatic cancer	0.000453	0.000707	CcSEcCtD
Pindolol—Headache—Epirubicin—pancreatic cancer	0.00045	0.000703	CcSEcCtD
Pindolol—Dizziness—Doxorubicin—pancreatic cancer	0.00044	0.000687	CcSEcCtD
Pindolol—Nausea—Epirubicin—pancreatic cancer	0.000427	0.000667	CcSEcCtD
Pindolol—Vomiting—Doxorubicin—pancreatic cancer	0.000423	0.000661	CcSEcCtD
Pindolol—Rash—Doxorubicin—pancreatic cancer	0.000419	0.000655	CcSEcCtD
Pindolol—Dermatitis—Doxorubicin—pancreatic cancer	0.000419	0.000654	CcSEcCtD
Pindolol—Headache—Doxorubicin—pancreatic cancer	0.000417	0.000651	CcSEcCtD
Pindolol—Nausea—Doxorubicin—pancreatic cancer	0.000395	0.000617	CcSEcCtD
Pindolol—ADRB3—Signaling Pathways—KDR—pancreatic cancer	0.000119	0.00033	CbGpPWpGaD
Pindolol—ADRB2—GPCR downstream signaling—PIK3CG—pancreatic cancer	0.000118	0.000329	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—JAG1—pancreatic cancer	0.000117	0.000326	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—SST—pancreatic cancer	0.000117	0.000326	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—NOTCH3—pancreatic cancer	0.000117	0.000325	CbGpPWpGaD
Pindolol—HTR1B—GPCR downstream signaling—PIK3CB—pancreatic cancer	0.000116	0.000323	CbGpPWpGaD
Pindolol—HTR1A—GPCR downstream signaling—PIK3CG—pancreatic cancer	0.000116	0.000321	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—JAG1—pancreatic cancer	0.000115	0.000319	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—TYMP—pancreatic cancer	0.000115	0.000318	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—NOTCH3—pancreatic cancer	0.000114	0.000318	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—CNR1—pancreatic cancer	0.000113	0.000314	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—SMAD4—pancreatic cancer	0.000113	0.000314	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—NFKBIA—pancreatic cancer	0.000113	0.000314	CbGpPWpGaD
Pindolol—HTR1B—GPCR downstream signaling—CXCL8—pancreatic cancer	0.000112	0.000311	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—NOTCH1—pancreatic cancer	0.000112	0.00031	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—CNR1—pancreatic cancer	0.000111	0.000308	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—HES1—pancreatic cancer	0.00011	0.000307	CbGpPWpGaD
Pindolol—ADRB1—Signaling by GPCR—PIK3CG—pancreatic cancer	0.00011	0.000305	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—PIK3CG—pancreatic cancer	0.000109	0.000304	CbGpPWpGaD
Pindolol—ADRB3—Signaling by GPCR—NRAS—pancreatic cancer	0.000109	0.000304	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—GCG—pancreatic cancer	0.000109	0.000304	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—CNR1—pancreatic cancer	0.000108	0.000301	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—EGF—pancreatic cancer	0.000108	0.0003	CbGpPWpGaD
Pindolol—ADRB2—Signaling by GPCR—PIK3CG—pancreatic cancer	0.000107	0.000298	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—GCG—pancreatic cancer	0.000107	0.000297	CbGpPWpGaD
Pindolol—ADRB1—GPCR downstream signaling—PIK3CD—pancreatic cancer	0.000106	0.000295	CbGpPWpGaD
Pindolol—HTR1B—Signaling by GPCR—PIK3CB—pancreatic cancer	0.000106	0.000294	CbGpPWpGaD
Pindolol—HTR1A—Signaling by GPCR—PIK3CG—pancreatic cancer	0.000105	0.000292	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—GCG—pancreatic cancer	0.000104	0.00029	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—AGTR1—pancreatic cancer	0.000104	0.00029	CbGpPWpGaD
Pindolol—ADRB2—GPCR downstream signaling—PIK3CD—pancreatic cancer	0.000104	0.000289	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—STK11—pancreatic cancer	0.000103	0.000285	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—AGTR1—pancreatic cancer	0.000102	0.000283	CbGpPWpGaD
Pindolol—HTR1A—GPCR downstream signaling—PIK3CD—pancreatic cancer	0.000102	0.000282	CbGpPWpGaD
Pindolol—HTR1B—Signaling by GPCR—CXCL8—pancreatic cancer	0.000101	0.000282	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—STK11—pancreatic cancer	0.0001	0.000279	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—AGTR1—pancreatic cancer	9.97e-05	0.000277	CbGpPWpGaD
Pindolol—ADRB3—Signaling by GPCR—EGFR—pancreatic cancer	9.95e-05	0.000277	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—STK11—pancreatic cancer	9.82e-05	0.000273	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—TERT—pancreatic cancer	9.66e-05	0.000269	CbGpPWpGaD
Pindolol—ADRB1—Signaling by GPCR—PIK3CD—pancreatic cancer	9.65e-05	0.000268	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—PIK3CD—pancreatic cancer	9.6e-05	0.000267	CbGpPWpGaD
Pindolol—ADRB3—GPCR downstream signaling—PIK3CA—pancreatic cancer	9.51e-05	0.000264	CbGpPWpGaD
Pindolol—ADRB2—Signaling by GPCR—PIK3CD—pancreatic cancer	9.44e-05	0.000262	CbGpPWpGaD
Pindolol—ADRB3—Signaling by GPCR—KRAS—pancreatic cancer	9.4e-05	0.000261	CbGpPWpGaD
Pindolol—ADRB1—GPCR downstream signaling—PIK3CB—pancreatic cancer	9.26e-05	0.000257	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—HIF1A—pancreatic cancer	9.24e-05	0.000257	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—GLP1R—pancreatic cancer	9.23e-05	0.000257	CbGpPWpGaD
Pindolol—HTR1A—Signaling by GPCR—PIK3CD—pancreatic cancer	9.23e-05	0.000257	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—TSC2—pancreatic cancer	9.22e-05	0.000256	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—DPYD—pancreatic cancer	9.08e-05	0.000252	CbGpPWpGaD
Pindolol—ADRB2—GPCR downstream signaling—PIK3CB—pancreatic cancer	9.06e-05	0.000252	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—APOE—pancreatic cancer	9.02e-05	0.000251	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—SMAD4—pancreatic cancer	8.99e-05	0.00025	CbGpPWpGaD
Pindolol—ADRB1—GPCR downstream signaling—CXCL8—pancreatic cancer	8.9e-05	0.000247	CbGpPWpGaD
Pindolol—HTR1A—GPCR downstream signaling—PIK3CB—pancreatic cancer	8.86e-05	0.000246	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—KDR—pancreatic cancer	8.84e-05	0.000246	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—SMAD4—pancreatic cancer	8.8e-05	0.000245	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—HES1—pancreatic cancer	8.78e-05	0.000244	CbGpPWpGaD
Pindolol—ADRB2—GPCR downstream signaling—CXCL8—pancreatic cancer	8.71e-05	0.000242	CbGpPWpGaD
Pindolol—ADRB3—Signaling by GPCR—PIK3CA—pancreatic cancer	8.64e-05	0.00024	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—SLC2A2—pancreatic cancer	8.62e-05	0.00024	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—SMAD4—pancreatic cancer	8.6e-05	0.000239	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—HES1—pancreatic cancer	8.59e-05	0.000239	CbGpPWpGaD
Pindolol—HTR1A—GPCR downstream signaling—CXCL8—pancreatic cancer	8.51e-05	0.000237	CbGpPWpGaD
Pindolol—ADRB1—Signaling by GPCR—PIK3CB—pancreatic cancer	8.41e-05	0.000234	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—NFKBIA—pancreatic cancer	8.41e-05	0.000234	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—HES1—pancreatic cancer	8.4e-05	0.000233	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—PIK3CB—pancreatic cancer	8.37e-05	0.000233	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—NOTCH1—pancreatic cancer	8.32e-05	0.000231	CbGpPWpGaD
Pindolol—ADRB2—Signaling by GPCR—PIK3CB—pancreatic cancer	8.23e-05	0.000229	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—PIK3CG—pancreatic cancer	8.14e-05	0.000226	CbGpPWpGaD
Pindolol—HTR1B—Signaling by GPCR—NRAS—pancreatic cancer	8.14e-05	0.000226	CbGpPWpGaD
Pindolol—ADRB1—Signaling by GPCR—CXCL8—pancreatic cancer	8.08e-05	0.000225	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—EGF—pancreatic cancer	8.05e-05	0.000224	CbGpPWpGaD
Pindolol—HTR1A—Signaling by GPCR—PIK3CB—pancreatic cancer	8.04e-05	0.000224	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—CXCL8—pancreatic cancer	8.04e-05	0.000224	CbGpPWpGaD
Pindolol—ADRB3—Signaling by GPCR—HRAS—pancreatic cancer	7.99e-05	0.000222	CbGpPWpGaD
Pindolol—ADRB2—Signaling by GPCR—CXCL8—pancreatic cancer	7.91e-05	0.00022	CbGpPWpGaD
Pindolol—ADRB3—GPCR downstream signaling—AKT1—pancreatic cancer	7.77e-05	0.000216	CbGpPWpGaD
Pindolol—HTR1A—Signaling by GPCR—CXCL8—pancreatic cancer	7.73e-05	0.000215	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—CASP3—pancreatic cancer	7.7e-05	0.000214	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—TERT—pancreatic cancer	7.69e-05	0.000214	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—TERT—pancreatic cancer	7.53e-05	0.000209	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—CCND1—pancreatic cancer	7.49e-05	0.000208	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—CTNNB1—pancreatic cancer	7.42e-05	0.000206	CbGpPWpGaD
Pindolol—HTR1B—Signaling by GPCR—EGFR—pancreatic cancer	7.42e-05	0.000206	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—TERT—pancreatic cancer	7.36e-05	0.000205	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—HIF1A—pancreatic cancer	7.36e-05	0.000205	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—TSC2—pancreatic cancer	7.34e-05	0.000204	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—MMP9—pancreatic cancer	7.27e-05	0.000202	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—PTEN—pancreatic cancer	7.23e-05	0.000201	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—HIF1A—pancreatic cancer	7.2e-05	0.0002	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—APOE—pancreatic cancer	7.18e-05	0.0002	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—TSC2—pancreatic cancer	7.18e-05	0.0002	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—PIK3CD—pancreatic cancer	7.16e-05	0.000199	CbGpPWpGaD
Pindolol—HTR1B—GPCR downstream signaling—PIK3CA—pancreatic cancer	7.09e-05	0.000197	CbGpPWpGaD
Pindolol—ADRB3—Signaling by GPCR—AKT1—pancreatic cancer	7.06e-05	0.000196	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—HIF1A—pancreatic cancer	7.04e-05	0.000196	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—KDR—pancreatic cancer	7.04e-05	0.000196	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—APOE—pancreatic cancer	7.03e-05	0.000195	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—TSC2—pancreatic cancer	7.02e-05	0.000195	CbGpPWpGaD
Pindolol—HTR1B—Signaling by GPCR—KRAS—pancreatic cancer	7.01e-05	0.000195	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—KDR—pancreatic cancer	6.88e-05	0.000191	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—APOE—pancreatic cancer	6.87e-05	0.000191	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—KDR—pancreatic cancer	6.73e-05	0.000187	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—SRC—pancreatic cancer	6.71e-05	0.000186	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—NFKBIA—pancreatic cancer	6.69e-05	0.000186	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—CD44—pancreatic cancer	6.67e-05	0.000186	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—NOTCH1—pancreatic cancer	6.63e-05	0.000184	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—NFKBIA—pancreatic cancer	6.55e-05	0.000182	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—VEGFA—pancreatic cancer	6.53e-05	0.000182	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—NOTCH1—pancreatic cancer	6.49e-05	0.00018	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—PIK3CG—pancreatic cancer	6.48e-05	0.00018	CbGpPWpGaD
Pindolol—ADRB1—Signaling by GPCR—NRAS—pancreatic cancer	6.48e-05	0.00018	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—STAT3—pancreatic cancer	6.47e-05	0.00018	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—NRAS—pancreatic cancer	6.45e-05	0.000179	CbGpPWpGaD
Pindolol—HTR1B—Signaling by GPCR—PIK3CA—pancreatic cancer	6.44e-05	0.000179	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—EGF—pancreatic cancer	6.41e-05	0.000178	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—NFKBIA—pancreatic cancer	6.4e-05	0.000178	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—GCG—pancreatic cancer	6.4e-05	0.000178	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—PIK3CG—pancreatic cancer	6.34e-05	0.000176	CbGpPWpGaD
Pindolol—ADRB2—Signaling by GPCR—NRAS—pancreatic cancer	6.34e-05	0.000176	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—NOTCH1—pancreatic cancer	6.34e-05	0.000176	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—EGF—pancreatic cancer	6.27e-05	0.000174	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—PIK3CB—pancreatic cancer	6.24e-05	0.000173	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—PIK3CG—pancreatic cancer	6.2e-05	0.000172	CbGpPWpGaD
Pindolol—HTR1A—Signaling by GPCR—NRAS—pancreatic cancer	6.2e-05	0.000172	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—EGF—pancreatic cancer	6.13e-05	0.00017	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—STK11—pancreatic cancer	6.02e-05	0.000167	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—MYC—pancreatic cancer	6.01e-05	0.000167	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—TGFB1—pancreatic cancer	6e-05	0.000167	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—CXCL8—pancreatic cancer	5.99e-05	0.000167	CbGpPWpGaD
Pindolol—HTR1B—Signaling by GPCR—HRAS—pancreatic cancer	5.96e-05	0.000166	CbGpPWpGaD
Pindolol—ADRB1—Signaling by GPCR—EGFR—pancreatic cancer	5.91e-05	0.000164	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—EGFR—pancreatic cancer	5.88e-05	0.000163	CbGpPWpGaD
Pindolol—HTR1B—GPCR downstream signaling—AKT1—pancreatic cancer	5.79e-05	0.000161	CbGpPWpGaD
Pindolol—ADRB2—Signaling by GPCR—EGFR—pancreatic cancer	5.78e-05	0.000161	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—CASP3—pancreatic cancer	5.74e-05	0.000159	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—PIK3CD—pancreatic cancer	5.7e-05	0.000158	CbGpPWpGaD
Pindolol—HTR1A—Signaling by GPCR—EGFR—pancreatic cancer	5.65e-05	0.000157	CbGpPWpGaD
Pindolol—ADRB1—GPCR downstream signaling—PIK3CA—pancreatic cancer	5.65e-05	0.000157	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—CCND1—pancreatic cancer	5.58e-05	0.000155	CbGpPWpGaD
Pindolol—ADRB1—Signaling by GPCR—KRAS—pancreatic cancer	5.58e-05	0.000155	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—PIK3CD—pancreatic cancer	5.58e-05	0.000155	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—KRAS—pancreatic cancer	5.55e-05	0.000154	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—CTNNB1—pancreatic cancer	5.53e-05	0.000154	CbGpPWpGaD
Pindolol—ADRB2—GPCR downstream signaling—PIK3CA—pancreatic cancer	5.52e-05	0.000154	CbGpPWpGaD
Pindolol—ADRB2—Signaling by GPCR—KRAS—pancreatic cancer	5.46e-05	0.000152	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—PIK3CD—pancreatic cancer	5.45e-05	0.000152	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—MMP9—pancreatic cancer	5.42e-05	0.000151	CbGpPWpGaD
Pindolol—HTR1A—GPCR downstream signaling—PIK3CA—pancreatic cancer	5.4e-05	0.00015	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—PTEN—pancreatic cancer	5.39e-05	0.00015	CbGpPWpGaD
Pindolol—HTR1A—Signaling by GPCR—KRAS—pancreatic cancer	5.34e-05	0.000148	CbGpPWpGaD
Pindolol—HTR1B—Signaling by GPCR—AKT1—pancreatic cancer	5.26e-05	0.000146	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—TYMS—pancreatic cancer	5.17e-05	0.000144	CbGpPWpGaD
Pindolol—ADRB1—Signaling by GPCR—PIK3CA—pancreatic cancer	5.13e-05	0.000143	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—PIK3CA—pancreatic cancer	5.1e-05	0.000142	CbGpPWpGaD
Pindolol—ADRB2—Signaling by GPCR—PIK3CA—pancreatic cancer	5.01e-05	0.000139	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—SRC—pancreatic cancer	5e-05	0.000139	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—PIK3CB—pancreatic cancer	4.97e-05	0.000138	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—TP53—pancreatic cancer	4.94e-05	0.000137	CbGpPWpGaD
Pindolol—HTR1A—Signaling by GPCR—PIK3CA—pancreatic cancer	4.9e-05	0.000136	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—VEGFA—pancreatic cancer	4.87e-05	0.000135	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—PIK3CB—pancreatic cancer	4.86e-05	0.000135	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—STAT3—pancreatic cancer	4.82e-05	0.000134	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—NRAS—pancreatic cancer	4.81e-05	0.000134	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—CXCL8—pancreatic cancer	4.77e-05	0.000133	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—PIK3CB—pancreatic cancer	4.75e-05	0.000132	CbGpPWpGaD
Pindolol—ADRB1—Signaling by GPCR—HRAS—pancreatic cancer	4.74e-05	0.000132	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—HRAS—pancreatic cancer	4.72e-05	0.000131	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—CXCL8—pancreatic cancer	4.67e-05	0.00013	CbGpPWpGaD
Pindolol—ADRB2—Signaling by GPCR—HRAS—pancreatic cancer	4.64e-05	0.000129	CbGpPWpGaD
Pindolol—ADRB1—GPCR downstream signaling—AKT1—pancreatic cancer	4.61e-05	0.000128	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—CASP3—pancreatic cancer	4.57e-05	0.000127	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—CXCL8—pancreatic cancer	4.57e-05	0.000127	CbGpPWpGaD
Pindolol—HTR1A—Signaling by GPCR—HRAS—pancreatic cancer	4.54e-05	0.000126	CbGpPWpGaD
Pindolol—ADRB2—GPCR downstream signaling—AKT1—pancreatic cancer	4.51e-05	0.000125	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—MYC—pancreatic cancer	4.48e-05	0.000125	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—CASP3—pancreatic cancer	4.47e-05	0.000124	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—TGFB1—pancreatic cancer	4.47e-05	0.000124	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—CCND1—pancreatic cancer	4.45e-05	0.000124	CbGpPWpGaD
Pindolol—HTR1A—GPCR downstream signaling—AKT1—pancreatic cancer	4.41e-05	0.000123	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—CTNNB1—pancreatic cancer	4.4e-05	0.000122	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—EGFR—pancreatic cancer	4.38e-05	0.000122	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—CASP3—pancreatic cancer	4.37e-05	0.000121	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—CCND1—pancreatic cancer	4.35e-05	0.000121	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—MMP9—pancreatic cancer	4.32e-05	0.00012	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—CTNNB1—pancreatic cancer	4.31e-05	0.00012	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—PTEN—pancreatic cancer	4.29e-05	0.000119	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—CCND1—pancreatic cancer	4.25e-05	0.000118	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—MMP9—pancreatic cancer	4.22e-05	0.000117	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—CTNNB1—pancreatic cancer	4.21e-05	0.000117	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—APOE—pancreatic cancer	4.21e-05	0.000117	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—PTEN—pancreatic cancer	4.2e-05	0.000117	CbGpPWpGaD
Pindolol—ADRB1—Signaling by GPCR—AKT1—pancreatic cancer	4.19e-05	0.000116	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—AKT1—pancreatic cancer	4.17e-05	0.000116	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—KRAS—pancreatic cancer	4.14e-05	0.000115	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—MMP9—pancreatic cancer	4.13e-05	0.000115	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—PTEN—pancreatic cancer	4.11e-05	0.000114	CbGpPWpGaD
Pindolol—ADRB2—Signaling by GPCR—AKT1—pancreatic cancer	4.1e-05	0.000114	CbGpPWpGaD
Pindolol—HTR1A—Signaling by GPCR—AKT1—pancreatic cancer	4.01e-05	0.000111	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—SRC—pancreatic cancer	3.98e-05	0.000111	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—SRC—pancreatic cancer	3.89e-05	0.000108	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—VEGFA—pancreatic cancer	3.88e-05	0.000108	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—STAT3—pancreatic cancer	3.84e-05	0.000107	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—NRAS—pancreatic cancer	3.83e-05	0.000106	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—SRC—pancreatic cancer	3.81e-05	0.000106	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—PIK3CA—pancreatic cancer	3.8e-05	0.000106	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—PIK3CG—pancreatic cancer	3.8e-05	0.000106	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—VEGFA—pancreatic cancer	3.79e-05	0.000105	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—STAT3—pancreatic cancer	3.76e-05	0.000104	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—NRAS—pancreatic cancer	3.75e-05	0.000104	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—VEGFA—pancreatic cancer	3.71e-05	0.000103	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—TP53—pancreatic cancer	3.68e-05	0.000102	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—STAT3—pancreatic cancer	3.67e-05	0.000102	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—PPARG—pancreatic cancer	3.67e-05	0.000102	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—NRAS—pancreatic cancer	3.66e-05	0.000102	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—MYC—pancreatic cancer	3.57e-05	9.92e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—TGFB1—pancreatic cancer	3.56e-05	9.89e-05	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—HRAS—pancreatic cancer	3.52e-05	9.78e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—MYC—pancreatic cancer	3.49e-05	9.7e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—EGFR—pancreatic cancer	3.49e-05	9.7e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—TGFB1—pancreatic cancer	3.48e-05	9.68e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—EGFR—pancreatic cancer	3.41e-05	9.49e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—MYC—pancreatic cancer	3.41e-05	9.49e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—TGFB1—pancreatic cancer	3.4e-05	9.46e-05	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—PIK3CD—pancreatic cancer	3.34e-05	9.28e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—EGFR—pancreatic cancer	3.34e-05	9.28e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—KRAS—pancreatic cancer	3.3e-05	9.16e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—KRAS—pancreatic cancer	3.22e-05	8.96e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—KRAS—pancreatic cancer	3.15e-05	8.76e-05	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—AKT1—pancreatic cancer	3.11e-05	8.64e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—PIK3CA—pancreatic cancer	3.03e-05	8.42e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—PIK3CA—pancreatic cancer	2.96e-05	8.23e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—TP53—pancreatic cancer	2.93e-05	8.14e-05	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—PIK3CB—pancreatic cancer	2.91e-05	8.09e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—PIK3CA—pancreatic cancer	2.9e-05	8.05e-05	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—PTGS2—pancreatic cancer	2.88e-05	8.02e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—TP53—pancreatic cancer	2.87e-05	7.97e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—TP53—pancreatic cancer	2.8e-05	7.79e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—HRAS—pancreatic cancer	2.8e-05	7.79e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—HRAS—pancreatic cancer	2.74e-05	7.62e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—HRAS—pancreatic cancer	2.68e-05	7.45e-05	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—PTEN—pancreatic cancer	2.51e-05	6.99e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—AKT1—pancreatic cancer	2.47e-05	6.88e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—AKT1—pancreatic cancer	2.42e-05	6.73e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—AKT1—pancreatic cancer	2.37e-05	6.58e-05	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—PIK3CA—pancreatic cancer	1.77e-05	4.93e-05	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—AKT1—pancreatic cancer	1.45e-05	4.03e-05	CbGpPWpGaD
